Sandor A, Crisan O, Marc G, Fizesan I, Ionut I, Moldovan C
Pharmaceutics. 2025; 17(2).
PMID: 40006627
PMC: 11860020.
DOI: 10.3390/pharmaceutics17020260.
Mehdikhani F, Hajimehdipoor H, Tansaz M, Maresca M, Rajabi S
Biomolecules. 2025; 15(2).
PMID: 40001571
PMC: 11852507.
DOI: 10.3390/biom15020268.
Choi D
Genomics Inform. 2025; 23(1):4.
PMID: 39934895
PMC: 11817428.
DOI: 10.1186/s44342-025-00038-3.
Chen D, Tan Y, Chen T, Wang Q, Yan Y, Zhao X
J Ovarian Res. 2025; 18(1):17.
PMID: 39875926
PMC: 11773766.
DOI: 10.1186/s13048-024-01580-4.
Wu J, Qian Y, Yang K, Zhang S, Zeng E, Luo D
Ann Med. 2025; 57(1):2453826.
PMID: 39847394
PMC: 11758805.
DOI: 10.1080/07853890.2025.2453826.
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives.
Zhang K, Zhu Y, Tang A, Zhou Z, Yang Y, Liu Z
Transl Oncol. 2025; 52:102272.
PMID: 39813769
PMC: 11783123.
DOI: 10.1016/j.tranon.2025.102272.
Long non-coding RNA CAR10 promotes angiogenesis of lung adenocarcinoma by mediating nuclear LDHA to epigenetically regulate VEGFA/C.
Ge X, Du C, Fang L, Xu W, Xiang J, Liu J
Commun Biol. 2025; 8(1):32.
PMID: 39789173
PMC: 11718007.
DOI: 10.1038/s42003-025-07452-x.
Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?.
Liu W, Kovacs A, Hou J
Cells. 2024; 13(23).
PMID: 39682769
PMC: 11640528.
DOI: 10.3390/cells13232022.
Translationally Controlled Tumor Protein Enhances Angiogenesis in Ovarian Tumors by Activating Vascular Endothelial Growth Factor Receptor 2 Signaling.
Rho S, Kim B, Lee S, Lee C
Biomol Ther (Seoul). 2024; 33(1):193-202.
PMID: 39664017
PMC: 11704413.
DOI: 10.4062/biomolther.2024.206.
Secreted Phospholipases A2: Drivers of Inflammation and Cancer.
Hidalgo I, Sorolla M, Sorolla A, Salud A, Parisi E
Int J Mol Sci. 2024; 25(22).
PMID: 39596471
PMC: 11594849.
DOI: 10.3390/ijms252212408.
Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma-Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein.
Elledge C, Zhang Y, Shin S, Cho H, Ramakrishnan S, Sankar A
Cells. 2024; 13(22).
PMID: 39594584
PMC: 11593053.
DOI: 10.3390/cells13221835.
Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis.
Yang T, Luo W, Yu J, Zhang H, Hu M, Tian J
Front Immunol. 2024; 15:1481296.
PMID: 39559360
PMC: 11570592.
DOI: 10.3389/fimmu.2024.1481296.
VEGF-Virus Interactions: Pathogenic Mechanisms and Therapeutic Applications.
Sanchez-Martinez C, Grueso E, Calvo-Lopez T, Martinez-Ortega J, Ruiz A, Almendral J
Cells. 2024; 13(21.
PMID: 39513922
PMC: 11545703.
DOI: 10.3390/cells13211815.
Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents.
Chaudhari P, Nemade A, Shirkhedkar A
RSC Adv. 2024; 14(45):33384-33417.
PMID: 39439843
PMC: 11495155.
DOI: 10.1039/d4ra05244g.
Obesity and leptin in breast cancer angiogenesis.
Lagarde C, Thapa K, Cullen N, Hawes M, Salim K, Benz M
Front Endocrinol (Lausanne). 2024; 15:1465727.
PMID: 39439572
PMC: 11493622.
DOI: 10.3389/fendo.2024.1465727.
Association of VEGFA polymorphisms with the risk of oesophageal cancer in Punjab, India: A case-control study.
Guleria K, Sambyal V, Walia S, Sudan M, Uppal M
Indian J Med Res. 2024; 159(5):502-510.
PMID: 39382410
PMC: 11463243.
DOI: 10.25259/ijmr_1862_22.
Role of Agrin in tissue repair and regeneration: From mechanisms to therapeutic opportunities (Review).
Li X, Xu Y, Si J, Gu F, Ma Y
Int J Mol Med. 2024; 54(5).
PMID: 39301653
PMC: 11410309.
DOI: 10.3892/ijmm.2024.5422.
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities.
Mahboobnia K, Beveridge D, Yeoh G, Kabir T, Leedman P
Int J Mol Sci. 2024; 25(17).
PMID: 39273339
PMC: 11395074.
DOI: 10.3390/ijms25179393.
Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update.
Bermudez M, Martinez-Barajas M, Bueno-Urquiza L, Lopez-Gutierrez J, Villegas-Mercado C, Lopez-Camarillo C
Cancers (Basel). 2024; 16(16).
PMID: 39199587
PMC: 11352763.
DOI: 10.3390/cancers16162814.
Interleukin 4 and cancer resistance in glioblastoma multiforme.
Detchou D, Barrie U
Neurosurg Rev. 2024; 47(1):448.
PMID: 39164434
DOI: 10.1007/s10143-024-02695-4.
